Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
0.1610
-0.0059 (-3.54%)
At close: Nov 6, 2026, 4:00 PM EST
0.1642
+0.0032 (1.99%)
After-hours: Nov 6, 2026, 7:06 PM EST

Arcadia Biosciences Revenue

Arcadia Biosciences had revenue of $1.44M in the quarter ending June 30, 2026, a decrease of -0.82%. This brings the company's total for the last twelve months to $4.75M, down -12.24% year-over-year. In the year 2025, Arcadia Biosciences had annual revenue of $4.86M, down -3.71%. That makes Arcadia Biosciences the 40,187th largest company in the world by revenue and 5,334th in the United States.

Revenue (ttm)
$4.75M
Revenue Growth
-12.24%
P/S Ratio
0.08
Revenue / Employee
$593,250
Employees
8
Market Cap
387.88K

Revenue Chart

Revenue by Geography

  • United States 4.90M 97.2%
  • Canada 109.00K 2.2%
  • Argentina 26.00K 0.5%
  • India 7.00K 0.1%
Fiscal year ended Dec 31, 2024 See the full Arcadia Biosciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.86M-187.00K-3.71%
Dec 31, 20245.05M591.00K13.27%
Dec 31, 20234.45M-2.96M-39.96%
Dec 31, 20227.42M638.00K9.41%
Dec 31, 20216.78M-1.25M-15.61%
Dec 31, 20208.03M6.87M587.25%
Dec 31, 20191.17M-295.00K-20.15%
Dec 31, 20181.46M-2.56M-63.64%
Dec 31, 20174.03M838.00K26.29%
Dec 31, 20163.19M-2.23M-41.12%
Dec 31, 20155.41M-1.57M-22.46%
Dec 31, 20146.98M504.00K7.78%
Dec 31, 20136.48M-532.00K-7.59%
Dec 31, 20127.01M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.